RU2009113812A - Композиции и способы для профилактики рака с помощью купредоксинов - Google Patents

Композиции и способы для профилактики рака с помощью купредоксинов Download PDF

Info

Publication number
RU2009113812A
RU2009113812A RU2009113812/10A RU2009113812A RU2009113812A RU 2009113812 A RU2009113812 A RU 2009113812A RU 2009113812/10 A RU2009113812/10 A RU 2009113812/10A RU 2009113812 A RU2009113812 A RU 2009113812A RU 2009113812 A RU2009113812 A RU 2009113812A
Authority
RU
Russia
Prior art keywords
azurin
patient
pharmaceutical composition
peptide according
cancer
Prior art date
Application number
RU2009113812/10A
Other languages
English (en)
Russian (ru)
Inventor
ГУПТА Тапас ДАС (US)
Гупта Тапас Дас
Ананда ЧАКРАБАРТИ (US)
Ананда Чакрабарти
Original Assignee
Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс (Us)
Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс (Us), Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс filed Critical Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс (Us)
Publication of RU2009113812A publication Critical patent/RU2009113812A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
RU2009113812/10A 2006-09-14 2007-09-13 Композиции и способы для профилактики рака с помощью купредоксинов RU2009113812A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
US60/844,358 2006-09-14

Publications (1)

Publication Number Publication Date
RU2009113812A true RU2009113812A (ru) 2010-10-20

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009113812/10A RU2009113812A (ru) 2006-09-14 2007-09-13 Композиции и способы для профилактики рака с помощью купредоксинов

Country Status (13)

Country Link
EP (1) EP2061498A4 (cg-RX-API-DMAC7.html)
JP (2) JP2010503409A (cg-RX-API-DMAC7.html)
KR (1) KR20090059152A (cg-RX-API-DMAC7.html)
CN (1) CN101595124A (cg-RX-API-DMAC7.html)
AU (1) AU2007296429A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0714987A2 (cg-RX-API-DMAC7.html)
CA (1) CA2663498A1 (cg-RX-API-DMAC7.html)
IL (1) IL197602A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009002787A (cg-RX-API-DMAC7.html)
NO (1) NO20091267L (cg-RX-API-DMAC7.html)
RU (1) RU2009113812A (cg-RX-API-DMAC7.html)
SG (1) SG174784A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008033987A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
UA97466C2 (ru) 2004-10-07 2012-02-27 Ананда Чакрабарти Транспортирующие соединения - производные купредоксина и способы их применения
US8232244B2 (en) 2007-02-08 2012-07-31 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
EP1904642A4 (en) 2005-07-19 2008-11-26 Univ Illinois TRANSPORT AGENTS FOR CROSS-BREAKING BLOOD-BRAIN DISEASE AND INTRUSION IN BRAIN CANCER CELLS AND METHOD OF USE THEREOF
AU2007329375A1 (en) 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
CA3075836A1 (en) * 2017-09-29 2019-04-04 Oncgnostics Gmbh Risk determination for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
UA97466C2 (ru) * 2004-10-07 2012-02-27 Ананда Чакрабарти Транспортирующие соединения - производные купредоксина и способы их применения
AU2006277009A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
WO2007024368A2 (en) * 2005-07-19 2007-03-01 The Board Of Trustees Of The University Of Illinois Compositions and methods to control angiogenesis with cupredoxins

Also Published As

Publication number Publication date
JP2010503409A (ja) 2010-02-04
WO2008033987A3 (en) 2009-04-30
AU2007296429A1 (en) 2008-03-20
CN101595124A (zh) 2009-12-02
SG174784A1 (en) 2011-10-28
KR20090059152A (ko) 2009-06-10
JP2014050390A (ja) 2014-03-20
MX2009002787A (es) 2009-08-27
CA2663498A1 (en) 2008-03-20
IL197602A0 (en) 2011-08-01
WO2008033987A2 (en) 2008-03-20
EP2061498A2 (en) 2009-05-27
EP2061498A4 (en) 2009-11-04
BRPI0714987A2 (pt) 2013-07-30
NO20091267L (no) 2009-06-04

Similar Documents

Publication Publication Date Title
JP2010503409A5 (cg-RX-API-DMAC7.html)
RU2009125599A (ru) Композиции и способы лечения рака cpg-богатой днк и купредоксинами
RU2009133473A (ru) Композиции и способы для предотвращения рака с помощью купредоксинов
TW487711B (en) Conjugates of lipophilic moieties and peptides
ES2521565T3 (es) Composiciones y métodos para el tratamiento de la esclerosis múltiple
BR0012200B1 (pt) composição de peptídeo para o tratamento de disfunção sexual e composição farmacêutica para o tratamento de disfunção sexual em um mamífero.
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
EA200501007A1 (ru) Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y2-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения
NZ578928A (en) Methods to increase mobility of hematopoietic stem cells by use of a lipopeptide compound and treatment of associated diseases
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
CN108472329A (zh) 多肽刺激免疫系统的用途
US20250255939A1 (en) Methods and compositions for inducing neural plasticity
US20060106049A1 (en) Histone deacetylase inhibitors and methods of use
WO2014198095A1 (zh) 镇痛肽fi及其基因和应用
JPH08511541A (ja) Des−tyrダイノルフィンおよび類似体に関する抗炎症組成物並びに方法
MXPA04010860A (es) Composiciones terapeuticas de 1,2,3,6-tetrahidropirimidin-2-ona y metodos para usarla.
CN114364691B (zh) 作为纤维化基质积累的抑制剂的肽
Papalia et al. The use of hyaluronic acid in the treatment of shoulder capsulitis: a systematic review
Surendran et al. Arthroscopic capsular release and continuous upper arm brachial block in frozen shoulder–A midterm outcome analysis
KIRBY et al. Treatment of staphylococcic infections with erythromycin
RU2008106231A (ru) Композиции и способы контроля ангиогенеза с помощью купредоксинов
JP2009502797A5 (cg-RX-API-DMAC7.html)
CA2219226A1 (en) Irritation relief using nonsteroidal anti-inflammatory compounds
Craven Treatment of obstructive atelectasis by aerosoladministration of proteolytic enzymes
Kalaivani Methamphetamine substance abuse and Dental Considerations: a modern era crisis